Delivery Order SPE2DB22D2218-SPE2DB26FR1QF
- Not listed
- The Defense Logistics Agency awarded a $1,010.01 delivery order to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal spray, with an ultimate completion date of October 29, 2025. This firm fixed-price contract, issued on October 28, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,391.00 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal spray on August 26, 2025, with completion scheduled for August 27, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $2,177.86 to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays on August 14, 2025, with ultimate completion by August 15, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $5,265.80 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays. The contract, designated as a firm fixed-price delivery order with no set-aside, was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform under this contract at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nayzilam 5 mg nasal sprays, with a ceiling value of $1,043.25. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor. The order...
- The Defense Logistics Agency awarded a delivery order valued at $1,755.65 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays under firm fixed price terms. The contract, which closed on October 30, 2025, with an ultimate completion date of October 31, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $6,114.51 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays. This firm fixed-price delivery order, issued on September 17, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the awardee's Conshohocken, Pennsylvania location, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays under a firm fixed-price contract valued at $1,043.25, with an ultimate completion date of July 31, 2025. This non-set-aside contract represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays, valued at $1,043.25. The contract was competitively awarded without set-aside designation on August 26, 2025, with an ultimate completion date of August 27, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,559.59 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays. This contract, awarded on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB26FR1QFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,020.05 to supply Nayzilam 5 mg nasal sprays, with an ultimate completion date of October 29, 2025. This is a firm fixed-price delivery order issued without set-aside designation, reflecting a competitively awarded contract. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The smaller Nayzilam delivery order exemplifies the company's role as a critical vendor for federal medical procurement, particularly in supplying specialized medications to Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/28/25 |